Search results for " costs" in Articles / App Notes
Article
Innovation vs. Capacity: How CMOs Compete
In Europe, in particular, government efforts to hold the line on healthcare costs have triggered a move away from branded generics to commodity generics that are procured by government tenders. Tender…
Article
Vaccine Development Faces Urgency and Challenges
Despite the proven effectiveness and value of vaccines, health agencies and insurers want lower prices, while conflicting regulations add to manufacturing costs.
For example, the transfer of produ…
Article
Fluid Handling in Biopharma Facilities
Industry experts discuss challenges, trends, and innovations in fluid handling.
By Susan Haigney
Contamination prevention in biopharmaceutical manufacturing is crucial, and the proper handling…
Article
Optimization of Protein Expression in Escherichia Coli
coli has many advantages—including rapid growth, ease of scale up, and low costs—but it poses challenges as well. Here, the authors discuss some parameters that can influence protein yields and qualit…
Article
Technologies and Practices Must Evolve to Meet Demand
Process development remained the top concern for survey respondents involved in the development of cells for tissue or cell-based therapies, followed by cell stability, scale up, and costs.
Techno…
Article
Securing the Single-Use Supply Chain
Although disposable systems do provide numerous advantages, such as reduced contamination risks, shorter set-up times, and lower capital costs, biopharmaceutical manufacturers do not have that same le…
Article
Improving PAT for Biologics
The complexity of biopharma processes requires innovative solutions.
Dec 01, 2014
By Cynthia Challener, PhD
BioPharm International
A key component of the quality-by-design (QbD) ap…
Article
New Era for Generic Drugs
Successful biosimilar development must consider manufacturing costs and quality commitments, pointed out Parexel Vice-President Cecil Nick at the September biosimilars conference sponsored by the Drug…
Article
2014 Manufacturing Trends and Outlook
Regulatory issues, costs, analytics, and inadequate bioreactor volumes were other challenges (see Table I).
Process analytical technologies
More than half of the responden…
Article
State of Quality and Compliance in the Biopharmaceutical Industry
Stakeholders are more demanding as healthcare costs continue to skyrocket. Patients are becoming more involved and demanding about their health. Additionally, there have been several R&D disappointmen…